Scaling-up malaria treatment: a review of the performance of different providers
- PMID: 23231707
- PMCID: PMC3547718
- DOI: 10.1186/1475-2875-11-414
Scaling-up malaria treatment: a review of the performance of different providers
Abstract
Background: Despite great progress towards malaria control, the disease continues to be a major public health problem in many developing countries, especially for poor women and children in remote areas. Resistance to artemisinin combination therapy (ACT) emerged in East Asia. Its spread would threaten the only effective malaria treatment currently available. Improvement in availability of diagnosis as part of malaria control has highlighted the fact that many fevers are not due to malaria. These fevers also need to be promptly diagnosed and adequately treated in order to improve public health outcomes in developing countries.
Methods: This review looked for evidence for the most effective approach to deliver malaria treatment in developing countries, by public sector, formal and informal private sector, and community health workers (CHWs). The authors analysed 31 studies to assess providers based on six parameters: knowledge and practice of provider, diagnosis, referral practices, price of medicine, availability of ACT, and treatment coverage and impact on morbidity and mortality.
Results: The public sector has made progress in prevention and treatment in many countries, but facilities are inaccessible to some communities, and the sector suffers shortages of health workers and stock-outs of medicines. Despite wide outreach, the private sector, especially informal facilities, presents public health risks. This is due to an inability to diagnose and treat non-malarial fevers, and an innate motive to over-prescribe malaria treatment. The need to pay for treatment is a major factor in deterring poor women and children from accessing the medicines they need. A system that depends on ability to pay risks a repeat of the chloroquine story, where an effective and cheap anti-malarial drug was rendered useless partly due to under-treatment. CHWs have proved to be effective agents in providing correct diagnosis and treatment of malaria and other common fevers, even in remote areas.
Conclusions: The evidence shows that there is no short-cut to investing in training and supervision of providers, or in treating malaria within a public health context rather than as a separate disease. The studies highlighted that all outlets face challenges in delivering their services, but that CHWs scored highly in almost all parameters. CHWs have proved to be effective agents in providing correct diagnosis and treatment of malaria and other common fevers, even in remote areas. Their role should be recognized and expanded.
Figures



Similar articles
-
Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries.Malar J. 2011 Oct 31;10:326. doi: 10.1186/1475-2875-10-326. Malar J. 2011. PMID: 22039838 Free PMC article.
-
Case management of malaria fever in Cambodia: results from national anti-malarial outlet and household surveys.Malar J. 2011 Oct 31;10:328. doi: 10.1186/1475-2875-10-328. Malar J. 2011. PMID: 22039922 Free PMC article.
-
Improving rational use of ACTs through diagnosis-dependent subsidies: Evidence from a cluster-randomized controlled trial in western Kenya.PLoS Med. 2018 Jul 17;15(7):e1002607. doi: 10.1371/journal.pmed.1002607. eCollection 2018 Jul. PLoS Med. 2018. PMID: 30016316 Free PMC article. Clinical Trial.
-
Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy!Acta Trop. 2005 Sep;95(3):305-15. doi: 10.1016/j.actatropica.2005.06.009. Acta Trop. 2005. PMID: 16098946 Review.
-
[Combined antimalarial therapy using artemisinin].Parassitologia. 2004 Jun;46(1-2):85-7. Parassitologia. 2004. PMID: 15305693 Review. Italian.
Cited by
-
The production and exportation of artemisinin-derived drugs in China: current status and existing challenges.Malar J. 2016 Jul 15;15:365. doi: 10.1186/s12936-016-1422-3. Malar J. 2016. PMID: 27421885 Free PMC article.
-
SMS messages increase adherence to rapid diagnostic test results among malaria patients: results from a pilot study in Nigeria.Malar J. 2014 Feb 25;13:69. doi: 10.1186/1475-2875-13-69. Malar J. 2014. PMID: 24564925 Free PMC article.
-
Do frontline health care providers know enough about artemisinin-based combination therapy to rationally treat malaria? A cross-sectional survey in Gezira State, Sudan.Malar J. 2015 Mar 26;14:131. doi: 10.1186/s12936-015-0652-0. Malar J. 2015. PMID: 25889428 Free PMC article.
-
Treatment-seeking patterns for malaria in pharmacies in five sub-Saharan African countries.Malar J. 2017 Aug 29;16(1):353. doi: 10.1186/s12936-017-1997-3. Malar J. 2017. PMID: 28851358 Free PMC article.
-
Success or failure of critical steps in community case management of malaria with rapid diagnostic tests: a systematic review.Malar J. 2014 Jun 12;13:229. doi: 10.1186/1475-2875-13-229. Malar J. 2014. PMID: 24924295 Free PMC article.
References
-
- WHO. Guidelines for the treatment of malaria. 2. 1999. http://whqlibdoc.who.int/publications/2010/9789241547925_eng.pdf (accessed 15 August 2012)
-
- Lemma H, Byass P, Desta A, Bosman A, Costanzo G, Toma L, Fottrell E, Marrast AC, Ambachew Y, Getachew A, Mulure N, Morrone A, Bianchi A, Barnabas GA. Deploying artemether-lumefantrine with rapid testing in Ethiopian communities: impact on malaria morbidity, mortality and healthcare resources. Trop Med Int Health. 2010;15:241–250. doi: 10.1111/j.1365-3156.2009.02447.x. - DOI - PubMed
-
- Otten M, Aregawi M, Were W, Karema C, Medin A, Bekele W, Jima D, Gausi K, Komatsu R, Korenromp E, Low-Beer D, Grabowsky M. Initial evidence of reduction of malaria cases and deaths in Rwanda and Ethiopia due to rapid scale-up of malaria prevention and treatment. Malar J. 2009;8:14. doi: 10.1186/1475-2875-8-14. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical